|
| | Publication Year | Title | Author(s) |
| 1 | Jun-2024 | The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury. | Katerelos, Marina ; Gleich, Kurt; Harley, Geoff ; Loh, Kim; Oakhill, Jonathan S; Kemp, Bruce E; de Souza, David P; Narayana, Vinod K; Coughlan, Melinda T; Laskowski, Adrienne; Ling, Naomi X Y; Murray-Segal, Lisa; Brink, Robert; Lee, Mardiana ; Power, David A ; Mount, Peter F |
| 2 | 1-Aug-2023 | Understanding Donor-derived Cell-free DNA in Kidney Transplantation: An Overview and Case-based Guide for Clinicians. | Graver, Alison S; Lee, Darren Hui Kwong ; Power, David A ; Whitlam, John B |
| 3 | 16-Feb-2023 | PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. | Schilperoort, Maaike; Ngai, David; Katerelos, Marina ; Power, David A ; Tabas, Ira |
| 4 | 2023 | Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney. | Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; Lee, Mardiana ; Mount, Peter F ; Power, David A |
| 5 | 2-Dec-2022 | Elevated serum urea-to-creatinine ratio is associated with adverse inpatient clinical outcomes in non-end stage chronic kidney disease. | Brookes, Elizabeth M; Power, David A |
| 6 | 1-Sep-2022 | Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin. | Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; de Souza, David P; Narayana, Vinod K; Kemp, Bruce E; Power, David A ; Mount, Peter F |
| 7 | 1-Jun-2022 | Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-sensitive Pathways. | Jha, Jay C; Dai, Aozhi; Garzarella, Jessica; Charlton, Amelia; Urner, Sofia; Østergaard, Jakob A; Okabe, Jun; Holterman, Chet E; Skene, Alison ; Power, David A ; Ekinci, Elif I ; Coughlan, Melinda T; Schmidt, Harald H H W; Cooper, Mark E; Touyz, Rhian M; Kennedy, Chris R; Jandeleit-Dahm, Karin |
| 8 | Nov-2021 | Serum potassium abnormalities in chronic kidney disease: prevalence, patient characteristics and clinical outcomes. | Brookes, Elizabeth M; Snider, Jonathan; Hart, Graeme K ; Robbins, Raymond J ; Power, David A |
| 9 | Oct-2021 | Dialysis and driving: an anonymous survey of patients receiving dialysis for end-stage kidney disease. | Graver, Alison; Odell, Morris; Churilov, Leonid ; Power, David A ; Mount, Peter F ; Davies, Matthew R P ; Choy, Suet-Wan ; Paizis, Kathy ; Cook, Natasha |
| 10 | 13-Dec-2020 | Serum potassium in chronic kidney disease: prevalence, patient characteristics and clinical outcomes. | Brookes, Elizabeth M; Snider, Jonathan; Hart, Graeme K ; Robbins, Raymond J ; Power, David A |
| 11 | 3-Sep-2020 | Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis. | Lee, Mardiana ; Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; Sullivan, Mitchell A; Laskowski, Adrienne; Coughlan, Melinda; Fraser, Scott A; Mount, Peter F ; Power, David A |
| 12 | Jan-2020 | Complement C5a Induces Renal Injury in Diabetic Kidney Disease Via Disruption in Mitochondrial Metabolic Agility. | Tan, Sih Min; Ziemann, Mark; Thallas-Bonke, Vicki; Snelson, Matthew; Kumar, Vinod; Laskowski, Adrienne; Nguyen, Tuong-Vi; Huynh, Kevin; Clarke, Michele V; Libianto, Renata; Baker, Scott T ; Skene, Alison ; Power, David A ; MacIsaac, Richard J; Henstridge, Darren C; Wetsel, Rick A; El-Osta, Assam; Meikle, Peter J; Wilson, Scott G; Forbes, Josephine M; Cooper, Mark E; Ekinci, Elif I ; Woodruff, Trent M; Coughlan, Melinda T |
| 13 | 26-Apr-2019 | Absence of the β1 subunit of AMP-activated protein kinase reduces myofibroblast infiltration of the kidneys in early diabetes. | Choy, Suet-Wan ; Fraser, Scott A; Katerelos, Marina ; Galic, Sandra; Kemp, Bruce E; Mount, Peter F ; Power, David A |
| 14 | Apr-2019 | Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction. | Whitlam, John B ; Ling, Ling; Skene, Alison ; Kanellis, John; Ierino, Francseco L; Slater, Howard R; Bruno, Damien L; Power, David A |
| 15 | 28-Feb-2019 | Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia. | Ellis, R; Katerelos, Marina ; Choy, Suet-Wan ; Cook, Natasha ; Lee, M ; Paizis, Kathy ; Pell, G; Walker, S ; Power, David A ; Mount, Peter F |
| 16 | 12-Feb-2019 | Three Dimensional Glomerular Reconstruction: A Novel Approach to Evaluate Renal Microanatomy in Diabetic Kidney Disease. | Torkamani, Niloufar ; Jerums, George ; Crammer, Paul; Skene, Alison ; Power, David A ; Panagiotopoulos, Sianna ; Clarke, Michele V; MacIsaac, Richard J; Ekinci, Elif I |
| 17 | Jan-2019 | Diabetes and higher HbA1c levels are independently associated with adverse renal outcomes in inpatients following multiple hospital admissions. | Torkamani, Niloufar ; Churilov, Leonid ; Robbins, Raymond J ; Jerums, George ; Beik, V; Radcliffe, N ; Patterson, S ; Bellomo, Rinaldo ; Burns, James D; Hart, Graeme K ; Lam, Que T ; Power, David A ; MacIsaac, Richard J; Johnson, D F; Zajac, Jeffrey; Ekinci, Elif I |
| 18 | 2019 | Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis. | Sellars, Marcus ; Clayton, Josephine M; Detering, Karen M ; Tong, Allison; Power, David A ; Morton, Rachael L |
| 19 | 17-Dec-2018 | Malignant Hypertension Causing a Pulmonary-Renal Syndrome. | Yong, Bryan; Power, David A |
| 20 | 2018 | Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin. | Lee, Mardiana ; Katerelos, Marina ; Gleich, Kurt; Galic, Sandra; Kemp, Bruce E; Mount, Peter F ; Power, David A |
Loading...
2
0
20
0
false
0000-0003-3983-0581